About HOOKIPA Pharma
HOOKIPA Pharma is a company based in Vienna (Austria) founded in 2011.. HOOKIPA Pharma has raised $133.72 million across 7 funding rounds from investors including Gilead, FFG Austrian Research Promotion Agency and Redmile Group. The company has 87 employees as of December 31, 2024. HOOKIPA Pharma operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Chimerix, Novavax and Generate Biomedicines, among others.
- Headquarter Vienna, Austria
- Employees 87 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hookipa Pharma Inc.
-
Annual Revenue
$43.95 M118.32as on Dec 31, 2024
-
Net Profit
$-43.5 M46.67as on Dec 31, 2024
-
EBITDA
$-42.03 M48.35as on Dec 31, 2024
-
Total Equity Funding
$133.72 M (USD)
in 7 rounds
-
Latest Funding Round
$21.25 M (USD), Post-IPO
Dec 20, 2023
-
Investors
Gilead
& 12 more
-
Employee Count
87
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HOOKIPA Pharma
HOOKIPA Pharma is a publicly listed company on the OTC with ticker symbol HOOK in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of HOOKIPA Pharma
HOOKIPA Pharma has successfully raised a total of $133.72M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $21.25 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $21.2M
-
First Round
First Round
(17 Oct 2011)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Post-IPO - HOOKIPA Pharma | Valuation |
investors |
|
| Feb, 2019 | Amount | Series D - HOOKIPA Pharma | Valuation | Redmile Group | |
| Dec, 2017 | Amount | Series C - HOOKIPA Pharma | Valuation | HBM Partners , Hillhouse |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HOOKIPA Pharma
HOOKIPA Pharma has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Gilead, FFG Austrian Research Promotion Agency and Redmile Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided by Samsara BioCapital in California.
|
Founded Year | Domain | Location | |
|
Long-term private equity investments in transformational opportunities are pursued.
|
Founded Year | Domain | Location | |
|
Late-stage life sciences investments are managed via VC and PE.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HOOKIPA Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HOOKIPA Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hookipa Pharma Comparisons
Competitors of HOOKIPA Pharma
HOOKIPA Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Chimerix, Novavax and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
|
| domain | founded_year | HQ Location |
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hookipa Pharma
Frequently Asked Questions about HOOKIPA Pharma
When was HOOKIPA Pharma founded?
HOOKIPA Pharma was founded in 2011.
Where is HOOKIPA Pharma located?
HOOKIPA Pharma is headquartered in Vienna, Austria.
Is HOOKIPA Pharma a funded company?
HOOKIPA Pharma is a funded company, having raised a total of $133.72M across 7 funding rounds to date. The company's 1st funding round was a Series C of $59.6M, raised on Oct 17, 2011.
How many employees does HOOKIPA Pharma have?
As of Dec 31, 2024, the latest employee count at HOOKIPA Pharma is 87.
What is the annual revenue of HOOKIPA Pharma?
Annual revenue of HOOKIPA Pharma is $43.95M as on Dec 31, 2024.
What does HOOKIPA Pharma do?
Developer of immunotherapies for the treatment of infectious diseases and cancer. The company uses a proprietary arenavirus platform to develop a product pipeline that inlcudes HB-201 and HB-202 for the treatment of Human Papillomavirus-16 positive (HPV16) cancers.
Who are the top competitors of HOOKIPA Pharma?
HOOKIPA Pharma's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Is HOOKIPA Pharma publicly traded?
Yes, HOOKIPA Pharma is publicly traded on OTC under the ticker symbol HOOK.
Who are HOOKIPA Pharma's investors?
HOOKIPA Pharma has 13 investors. Key investors include Gilead, FFG Austrian Research Promotion Agency, Redmile Group, Samsara BioCapital, and Invus.
What is HOOKIPA Pharma's ticker symbol?
The ticker symbol of HOOKIPA Pharma is HOOK on OTC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.